Information

Dear user, the application need JavaScript support. Please enable JavaScript in your browser.

You search for a phrase ""Complement Inactivating Agents therapeutic use"" according to the criterion: All Text


Showing 1-1 from 1 results
Title:
Pharmacokinetic and Pharmacodynamic Evaluation of Ravulizumab in Adults with Severe Coronavirus Disease 2019.
Authors:
McEneny-King AC; Clinical Development and Translational Sciences, Clinical Pharmacology, Alexion Pharmaceuticals, Boston, MA, USA.
Monteleone JPR; Clinical Development and Translational Sciences, Pharmacometrics, Alexion Pharmaceuticals, Boston, MA, USA.
Kazani SD; Clinical Development and Translational Sciences, Alexion Pharmaceuticals, Boston, MA, USA.
Ortiz SR; Clinical Development and Translational Sciences, Clinical Pharmacology, Alexion Pharmaceuticals, Boston, MA, USA. .
Show more
Source:
Infectious diseases and therapy [Infect Dis Ther] 2021 Jun; Vol. 10 (2), pp. 1045-1054. Date of Electronic Publication: 2021 Apr 07.
Publication Type:
Journal Article
Academic Journal
    Showing 1-1 from 1 results

    We use cookies to help identify your computer so we can tailor your user experience, track shopping basket contents and remember where you are in the order process.